{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:05:14Z","timestamp":1792641914136,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejso.2025.111375","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:59:45Z","timestamp":1767027585000},"page":"111375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tailoring axillary treatment in patients with isolated locoregional recurrent breast cancer"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1395-2520","authenticated-orcid":false,"given":"Tess I.M.","family":"Snellen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goedele S.N.J.","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid N.","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent O.","family":"Dezentj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-7005","authenticated-orcid":false,"given":"Terry","family":"Wiersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederieke H.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-4257","authenticated-orcid":false,"given":"Marie-Jeanne T.F.D","family":"Vrancken Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2025.111375_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10549-017-4340-3","article-title":"Patterns and predictors of first and subsequent recurrence in women with early breast cancer","volume":"165","author":"Geurts","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejso.2025.111375_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-018-4944-2","article-title":"Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact","volume":"173","author":"Houvenaeghel","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.ejso.2025.111375_bib3","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials","volume":"24","author":"Wapnir","year":"2006","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2025.111375_bib4","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer","volume":"27","author":"Anderson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.111375_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.111375_bib6","first-page":"19","article-title":"Current strategies for the management of locoregional breast cancer recurrence","volume":"33","author":"Wapnir","year":"2019","journal-title":"Oncology (Williston Park)"},{"issue":"20","key":"10.1016\/j.ejso.2025.111375_bib7","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1200\/JCO.19.02806","article-title":"Multidisciplinary management of locoregional recurrent breast cancer","volume":"38","author":"Buchholz","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.111375_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12609-020-00392-x","article-title":"Regional nodal recurrence after treatment for breast cancer","volume":"12","author":"Albright","year":"2020","journal-title":"Current Breast Cancer Reports"},{"issue":"7","key":"10.1016\/j.ejso.2025.111375_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clbc.2017.03.008","article-title":"Management of isolated locoregional recurrences in breast cancer: a review of local and systemic modalities","volume":"17","author":"Wadasadawala","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ejso.2025.111375_bib10","doi-asserted-by":"crossref","first-page":"S508","DOI":"10.1016\/S0167-8140(25)00847-3","article-title":"2101 local management of second breast cancer event after primary breast conserving therapy: international DELPHI consensus","volume":"206","author":"Hannoun-Levi","year":"2025","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.111375_bib11","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","article-title":"Understanding breast cancer complexity to improve patient outcomes: the St gallen international consensus conference for the primary therapy of individuals with early breast cancer 2023","volume":"34","author":"Curigliano","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2025.111375_bib12","series-title":"NCCN clinical practice guidelines in oncology: Breast cancer. Version 4.2025 fort Washington, PA, USA","year":"2025"},{"issue":"24","key":"10.1016\/j.ejso.2025.111375_bib13","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.111375_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2023.06.011","article-title":"This house believes that: MARI\/TAD is better than sentinel node biopsy after PST for cN+ patients","volume":"71","author":"van Hemert","year":"2023","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejso.2025.111375_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.111375_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104411","article-title":"Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol","volume":"80","author":"van Hemert","year":"2025","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ejso.2025.111375_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","article-title":"Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-Protocol","volume":"193","author":"van Loevezijn","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejso.2025.111375_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2025.2752","article-title":"Iodine seed-marking protocol for response-guided axillary treatment after systemic therapy for node-positive breast cancer","author":"van Hemert","year":"2025","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.111375_bib19","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/annonc\/mdv106","article-title":"Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the assessment of time-to-event endpoints in CANcer trials)","volume":"26","author":"Gourgou-Bourgade","year":"2015","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.111375_bib20","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","article-title":"Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial","volume":"36","author":"Wapnir","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.111375_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/annonc\/mdg347","article-title":"Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\/82) comparing tamoxifen with observation","volume":"14","author":"Waeber","year":"2003","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2025.111375_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e43069","article-title":"Pathologic complete response and breast cancer survival post-neoadjuvant chemotherapy: a systematic review and meta-analysis of real-world data","volume":"11","author":"Antonini","year":"2025","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.ejso.2025.111375_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.ejso.2025.111375_bib24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ejso.2010.05.009","article-title":"Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure","volume":"36","author":"Derkx","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.111375_bib25","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archsurg.141.9.867","article-title":"Management and outcomes of isolated axillary node recurrence in breast cancer","volume":"141","author":"Konkin","year":"2006","journal-title":"Arch Surg"},{"issue":"4","key":"10.1016\/j.ejso.2025.111375_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9610(00)00456-6","article-title":"Presentation, management and outcome of axillary recurrence from breast cancer","volume":"180","author":"Newman","year":"2000","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.ejso.2025.111375_bib27","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.ijrobp.2008.06.1955","article-title":"Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma","volume":"73","author":"Lukens","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejso.2025.111375_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1365-2168.2001.01637.x","article-title":"Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer","volume":"88","author":"de Boer","year":"2001","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.ejso.2025.111375_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163254","article-title":"Clinicopathological features and prognostic factors affecting survival outcomes in isolated locoregional recurrence of breast cancer: single-institutional series","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejso.2025.111375_bib30","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1245\/ASO.2003.01.017","article-title":"Outcomes after localized axillary node recurrence in breast cancer","volume":"10","author":"Wright","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.111375_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2006.04.006","article-title":"Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials","volume":"79","author":"Nielsen","year":"2006","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.111375_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/SLA.0000000000005671","article-title":"Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis","volume":"277","author":"Che","year":"2023","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.111375_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.adro.2019.09.006","article-title":"Regional recurrence rates with or without complete axillary dissection for breast cancer patients with node-positive disease on sentinel lymph node biopsy after neoadjuvant chemotherapy","volume":"5","author":"Ling","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.111375_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-004-6276-7","article-title":"Effect of axillary lymphadenectomy on breast carcinoma survival","volume":"91","author":"Joslyn","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2025.111375_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.111375_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000002354","article-title":"Axillary dissection and nodal irradiation can be avoided for Most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients","volume":"266","author":"Morrow","year":"2017","journal-title":"Ann Surg"},{"issue":"9938","key":"10.1016\/j.ejso.2025.111375_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ejso.2025.111375_bib38","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1245\/s10434-015-4714-x","article-title":"Neoadjuvant chemotherapy for breast cancer, is practice changing? A population-based review of current surgical trends","volume":"22","author":"Graham","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.111375_bib39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4274\/imj.galenos.2024.96266","article-title":"Relationship of neoadjuvant chemotherapy efficacy with histopathologic molecular subtypes in breast cancer patients","volume":"25","author":"Y\u0131ld\u0131r\u0131m","year":"2024","journal-title":"Istanbul Med J"},{"issue":"18","key":"10.1016\/j.ejso.2025.111375_bib40","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325018037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325018037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:31:05Z","timestamp":1783737065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325018037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0748798325018037"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111375","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailoring axillary treatment in patients with isolated locoregional recurrent breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111375"}}